NK cells can realize cytotoxic potential against tumor cells via both the granule-mediated cytotoxicity mechanism involving perforin and granzyme B, and the receptor-mediated mechanism through cytokine TRAIL release, or the expression of surface FasL [6] (Figure 1). The gene discussed is PRF1; the disease is neoplasm.